219 related articles for article (PubMed ID: 26285134)
1. Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate.
Dueregger A; Schöpf B; Eder T; Höfer J; Gnaiger E; Aufinger A; Kenner L; Perktold B; Ramoner R; Klocker H; Eder IE
PLoS One; 2015; 10(8):e0135704. PubMed ID: 26285134
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells.
Vaughan RA; Garcia-Smith R; Trujillo KA; Bisoffi M
Prostate; 2013 Oct; 73(14):1538-46. PubMed ID: 23818177
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria: The ketogenic diet--A metabolism-based therapy.
Vidali S; Aminzadeh S; Lambert B; Rutherford T; Sperl W; Kofler B; Feichtinger RG
Int J Biochem Cell Biol; 2015 Jun; 63():55-9. PubMed ID: 25666556
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and the metabolic phenotype of prostate cancer cells.
Higgins LH; Withers HG; Garbens A; Love HD; Magnoni L; Hayward SW; Moyes CD
Biochim Biophys Acta; 2009 Dec; 1787(12):1433-43. PubMed ID: 19524545
[TBL] [Abstract][Full Text] [Related]
5. Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes.
Sadeghi RN; Karami-Tehrani F; Salami S
Tumour Biol; 2015 Apr; 36(4):2893-905. PubMed ID: 25501281
[TBL] [Abstract][Full Text] [Related]
6. Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.
Marín de Mas I; Aguilar E; Zodda E; Balcells C; Marin S; Dallmann G; Thomson TM; Papp B; Cascante M
PLoS Comput Biol; 2018 Jan; 14(1):e1005914. PubMed ID: 29293497
[TBL] [Abstract][Full Text] [Related]
7. Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells.
Mizumachi T; Muskhelishvili L; Naito A; Furusawa J; Fan CY; Siegel ER; Kadlubar FF; Kumar U; Higuchi M
Prostate; 2008 Mar; 68(4):408-17. PubMed ID: 18196528
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of tissue ω-6 and ω-3 polyunsaturated fatty acids (PUFA) in benign and malignant pathologic stage pT2a radical prostatectomy specimens.
Schumacher MC; Laven B; Petersson F; Cederholm T; Onelöv E; Ekman P; Brendler C
Urol Oncol; 2013 Apr; 31(3):318-24. PubMed ID: 21414816
[TBL] [Abstract][Full Text] [Related]
9. Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach.
Liu Y; Zuckier LS; Ghesani NV
Anticancer Res; 2010 Feb; 30(2):369-74. PubMed ID: 20332441
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.
Liu Y
Prostate Cancer Prostatic Dis; 2006; 9(3):230-4. PubMed ID: 16683009
[TBL] [Abstract][Full Text] [Related]
11. Jacaric acid and its octadecatrienoic acid geoisomers induce apoptosis selectively in cancerous human prostate cells: a mechanistic and 3-D structure-activity study.
Gasmi J; Thomas Sanderson J
Phytomedicine; 2013 Jun; 20(8-9):734-42. PubMed ID: 23453308
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.
Moro L; Arbini AA; Yao JL; di Sant'Agnese PA; Marra E; Greco M
Cell Death Differ; 2009 Apr; 16(4):571-83. PubMed ID: 19079138
[TBL] [Abstract][Full Text] [Related]
13. Hepatic fatty acid-supported respiration in rats fed an energy-dense diet.
Liverini G; Iossa S; Mollica MP; Lionetti L; Barletta A
Cell Biochem Funct; 1996 Dec; 14(4):283-9. PubMed ID: 8952047
[TBL] [Abstract][Full Text] [Related]
14. Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer.
Fidelito G; De Souza DP; Niranjan B; De Nardo W; Keerthikumar S; Brown K; Taylor RA; Watt MJ
Mol Cancer Res; 2023 Apr; 21(4):359-373. PubMed ID: 36574015
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic capacities of metabolic fuel use in cuttlefish (Sepia officinalis) and responses to food deprivation: insight into the metabolic organization and starvation survival strategy of cephalopods.
Speers-Roesch B; Callaghan NI; MacCormack TJ; Lamarre SG; Sykes AV; Driedzic WR
J Comp Physiol B; 2016 Aug; 186(6):711-25. PubMed ID: 27138338
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial oncobioenergetic index: A potential biomarker to predict progression from indolent to aggressive prostate cancer.
Vayalil PK; Landar A
Oncotarget; 2015 Dec; 6(40):43065-80. PubMed ID: 26515588
[TBL] [Abstract][Full Text] [Related]
17. Carnitine supplementation and ketogenesis by small-for-date neonates on medium-and long-chain fatty acid formulae.
Labadaridis J; Mavridou I; Sarafidou G; Alexiou N; Costalos C; Michelakakis H
Biol Neonate; 2000; 77(1):25-8. PubMed ID: 10658827
[TBL] [Abstract][Full Text] [Related]
18. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial free fatty acid β-oxidation supports oxidative phosphorylation and proliferation in cancer cells.
Rodríguez-Enríquez S; Hernández-Esquivel L; Marín-Hernández A; El Hafidi M; Gallardo-Pérez JC; Hernández-Reséndiz I; Rodríguez-Zavala JS; Pacheco-Velázquez SC; Moreno-Sánchez R
Int J Biochem Cell Biol; 2015 Aug; 65():209-21. PubMed ID: 26073129
[TBL] [Abstract][Full Text] [Related]
20. Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance.
Moreel X; Allaire J; Léger C; Caron A; Labonté MÈ; Lamarche B; Julien P; Desmeules P; Têtu B; Fradet V
Cancer Prev Res (Phila); 2014 Jul; 7(7):766-76. PubMed ID: 24824038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
